Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 43/72 ]
NASDAQ | Common Stock
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases.
It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF.
The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally.
CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jul 29, 24 | -0.65 Decreased by -16.07% | -0.55 Decreased by -18.18% |
| Apr 30, 24 | -1.04 Decreased by -89.09% | -0.54 Decreased by -92.59% |
| Jan 25, 24 | -0.44 Increased by +13.73% | -0.54 Increased by +18.52% |
| Oct 26, 23 | -0.43 Increased by +10.42% | -0.58 Increased by +25.86% |
| Jul 25, 23 | -0.56 Decreased by -3.70% | -0.58 Increased by +3.45% |
| Apr 27, 23 | -0.55 Decreased by -12.24% | -0.56 Increased by +1.79% |
| Jan 26, 23 | -0.51 Increased by +1.92% | -0.56 Increased by +8.93% |
| Nov 1, 22 | -0.48 Decreased by -60.00% | -0.56 Increased by +14.29% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 10.51 M Increased by +69.92% | -9.01 M Increased by +8.33% | Decreased by -85.73% Increased by +46.05% |
| Jun 30, 23 | 9.50 M Increased by +88.83% | -11.65 M Decreased by -5.24% | Decreased by -122.64% Increased by +44.27% |
| Mar 31, 23 | 7.98 M Increased by +95.76% | -11.37 M Decreased by -13.84% | Decreased by -142.55% Increased by +41.84% |
| Dec 31, 22 | 7.18 M Increased by +96.17% | -10.54 M Increased by +0.32% | Decreased by -146.82% Increased by +49.19% |
| Sep 30, 22 | 6.19 M Increased by +82.21% | -9.83 M Decreased by -60.28% | Decreased by -158.91% Increased by +12.03% |
| Jun 30, 22 | 5.03 M Increased by +61.10% | -11.07 M Increased by +37.62% | Decreased by -220.06% Increased by +61.28% |
| Mar 31, 22 | 4.08 M Increased by +42.52% | -9.99 M Decreased by -15.81% | Decreased by -245.12% Increased by +18.74% |
| Dec 31, 21 | 3.66 M Increased by +75.19% | -10.57 M Decreased by -210.70% | Decreased by -288.96% Decreased by -77.35% |